Xiamen C&D Corporation

Total investments

36

Average round size

90M

Portfolio companies

33

Rounds per year

0.82

Lead investments

5

Follow on index

0.08

Exits

1

Areas of investment
BiotechnologyE-CommerceInternetHealth CareHealth DiagnosticsManufacturingMedicalPharmaceuticalElectronicsMedia and Entertainment

Summary

In 1980 was created Xiamen C&D Corporation, which is appeared as Corporate Investor. The venture was found in Asia in China. The main department of described Corporate Investor is located in the Xiamen.

Among the various public portfolio startups of the fund, we may underline Microidea Technology, Yingsheng Biology, Skylimit Entertainment Group The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular fund investment industries, there are Health Care, Social Media.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Xiamen C&D Corporation, startups are often financed by ZhenFund, Yahui Precision Medicine Fund, Source Capital. The meaningful sponsors for the fund in investment in the same round are Shenzhen Weiyue Creative Investment Co., ZhenFund, Weibo. In the next rounds fund is usually obtained by Toutoushidao Capital, Shenzhen Weiyue Creative Investment Co., Qualcomm Ventures.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. The top activity for fund was in 2018. The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies.

Show more

Investments analytics

Analytics

Total investments
36
Lead investments
5
Exits
1
Rounds per year
0.82
Follow on index
0.08
Investments by industry
  • Health Care (9)
  • Manufacturing (8)
  • Pharmaceutical (6)
  • E-Commerce (5)
  • Biotechnology (4)
  • Show 40 more
Investments by region
  • China (33)
  • United States (1)
  • Finland (1)
Peak activity year
2023
Number of Unicorns
2
Number of Decacorns
2
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Avg. valuation at time of investment
122M
Group Appearance index
0.89
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Rongshujia 27 Mar 2024 Health Care, Health Diagnostics, Medical Early Stage Venture Shanghai, Minhang, China
VectorBuilder Inc 07 Oct 2022 E-Commerce, Online Portals Late Stage Venture 63M United States, California, Santa Clara
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.